Clinical Trial Update: Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation [Phase 4]

View source ↗

Summary

A Phase 4 trial update comparing three vs twelve months of dual antiplatelet therapy after stent implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Snippet

Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. | Conditions: Drug-Eluting Stents, Percutaneous Coronary Intervention | Phase 4 | Status: UNKNOWN